Antioxidants and Redox Signaling · 2016 · 126 citations · 42 references
MedicineCardiologyPharmacologyEnzymologyExperimental PharmacologyMolecular PharmacologyCardiovascular Molecular PhysiologyCardiovascular PharmacologyOxidative StressOxidative Stress MechanismsArterial StiffnessLysyl Oxidase Cross-linkingLysyl Oxidase InhibitionOxidative Stress In Cardiovascular DiseaseOxidative Stress InjuryReactive Oxygen Species SignalingVascular Smooth Muscle DysfunctionVascular Stiffness
Aims: Vascular stiffness, structural elastin abnormalities, and increased oxidative stress are hallmarks of hypertension. Lysyl oxidase (LOX) is an elastin crosslinking enzyme that produces H 2 O 2 as a by-product. We addressed the interplay between LOX, oxidative stress, vessel stiffness, and elastin. Results: Angiotensin II (Ang II)-infused hypertensive mice and spontaneously hypertensive rats (SHR) showed increased vascular LOX expression and stiffness and an abnormal elastin structure. Mice over-expressing LOX in vascular smooth muscle cells (TgLOX) exhibited similar mechanical and elastin alterations to those of hypertensive models. LOX inhibition with β-aminopropionitrile (BAPN) attenuated mechanical and elastin alterations in TgLOX mice, Ang II-infused mice, and SHR. Arteries from TgLOX mice, Ang II-infused mice, and/or SHR exhibited increased vascular H 2 O 2 and O 2 .− levels, NADPH oxidase activity, and/or mitochondrial dysfunction. BAPN prevented the higher oxidative stress in hypertensive models. Treatment of TgLOX and Ang II-infused mice and SHR with the mitochondrial-targeted superoxide dismutase mimetic mito-TEMPO, the antioxidant apocynin, or the H 2 O 2 scavenger polyethylene glycol-conjugated catalase (PEG-catalase) reduced oxidative stress, vascular stiffness, and elastin alterations. Vascular p38 mitogen-activated protein kinase (p38MAPK) activation was increased in Ang II-infused and TgLOX mice and this effect was prevented by BAPN, mito-TEMPO, or PEG-catalase. SB203580, the p38MAPK inhibitor, normalized vessel stiffness and elastin structure in TgLOX mice. Innovation: We identify LOX as a novel source of vascular reactive oxygen species and a new pathway involved in vascular stiffness and elastin remodeling in hypertension. Conclusion: LOX up-regulation is associated with enhanced oxidative stress that promotes p38MAPK activation, elastin structural alterations, and vascular stiffness. This pathway contributes to vascular abnormalities in hypertension. Antioxid. Redox Signal. 27, 379–397.
42
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Anna Dikalova, Alfiya Bikineyeva, Klaudia Budzyn et al. · Circulation Research · 2010 · 728 citations · Full text
Prognostic Significance of Small-Artery Structure in Hypertension
Damiano Rizzoni, Enzo Porteri, Gianluca E.M. Boari et al. · Circulation · 2003 · 492 citations
Medicine, Cardiology, Endocrinology +14